InsidersTradesSigma
METLIFE INC Stock: price and directors' dealings · United States · SEC (Form 4)
Follow the METLIFE INC share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Banks sector, METLIFE INC has published 507 public disclosures. The latest transaction was reported on 11 June 2026 (Attribution). Among the most active insiders: Herzog David L. All data is accessible without an account.
507
Insider Decl.
0
Thresholds
€9,262
2 ops.
Buy Volume
€7m
13 ops.
Sell Volume
26Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 11 June 2026
Declarations507 total
7 sharesCommon StockSEC:0001420864-26-000018:0
26,000 shares@ US$80.487824.6% of flowCommon StockSEC:0001787586-25-000002:0
353 shares@ US$75.77100.0% of flowCommon StockSEC:0002066326-25-000004:0
540 shares0Common StockSEC:0001099219-25-000118:0
540 shares@ US$81.1611.8% of flowCommon StockSEC:0001099219-25-000119:0
540 shares@ US$81.164.9% of flowCommon StockSEC:0001099219-25-000111:0
540 shares@ US$81.164.2% of flowCommon StockSEC:0001099219-25-000115:0
540 shares0Common StockSEC:0001099219-25-000121:0
540 shares0Common StockSEC:0001099219-25-000120:0
540 shares@ US$81.1618.2% of flowCommon StockSEC:0001099219-25-000112:0
540 shares@ US$81.1610.3% of flowCommon StockSEC:0001099219-25-000122:0
540 shares@ US$81.163.0% of flowCommon StockSEC:0001099219-25-000116:0
540 shares@ US$81.164.0% of flowCommon StockSEC:0001099219-25-000113:0
218 shares@ US$81.164.0% of flowCommon StockSEC:0001099219-25-000117:0
925 shares@ US$81.163.6% of flowCommon StockSEC:0001099219-25-000114:0
144 shares@ US$78.451.3% of flowCommon StockSEC:0001099219-25-000094:0
21 shares@ US$78.450.4% of flowCommon StockSEC:0001099219-25-000095:0
39 shares@ US$78.450.7% of flowCommon StockSEC:0001099219-25-000091:0
291 shares@ US$78.452.1% of flowCommon StockSEC:0001099219-25-000093:0
621 shares@ US$78.452.3% of flowCommon StockSEC:0001099219-25-000087:0
251 shares@ US$78.451.9% of flowCommon StockSEC:0001099219-25-000090:0
572 shares@ US$78.453.1% of flowCommon StockSEC:0001099219-25-000092:0
18 shares@ US$78.450.6% of flowCommon StockSEC:0001099219-25-000089:0
46 shares@ US$78.450.8% of flowCommon StockSEC:0001099219-25-000088:0
2,866 shares@ US$85.708.6% of flowCommon StockSEC:0001099219-25-000073:0
25 of 507 declarations
About METLIFE INC
MetLife Inc. (NYSE: MET) is a major U.S.-listed insurance and financial services group, headquartered in New York at 200 Park Avenue. Founded in 1868, the company has grown into a global franchise with operations in more than 40 markets and leading positions across the United States, Asia, Latin America, Europe, and the Middle East. For investors, MetLife is a large-cap, diversified insurance platform with a strong international footprint and a long operating history in the United States market. ([metlife.com](https://www.metlife.com/about-us/newsroom/2026/january/metlife-recognized-as-industry-leader-on-fortune-worlds-most-admired-companies-2026-List/)) MetLife’s core business spans life insurance, annuities, employee benefits, and asset management. Its operating model is built around several complementary businesses. Group Benefits serves employers with life, disability, dental, vision, accident, and health protection, alongside wellness-related solutions and voluntary benefits. Retirement & Income Solutions (RIS) focuses on institutional retirement offerings such as pension risk transfer, stable value, institutional income annuities, benefits funding, and structured settlements. The company also runs international businesses in Asia, Latin America, and EMEA, giving it exposure to multiple insurance growth markets and reducing reliance on any single geography. ([metlife.com](https://www.metlife.com/work/?utm_source=openai)) From a competitive standpoint, MetLife is one of the most recognizable names in global life and health insurance. Its scale, brand strength, long-dated liability expertise, and broad B2B distribution network support a durable competitive position. In January 2026, MetLife was ranked No. 1 in the Insurance: Life and Health industry on Fortune’s World’s Most Admired Companies list for the seventh consecutive year, highlighting its reputation for financial strength, execution, and market leadership. The company also emphasizes deep expertise in institutional annuities and pension de-risking, areas where long-term relationships and balance-sheet credibility matter materially. ([metlife.com](https://www.metlife.com/about-us/newsroom/2026/january/metlife-recognized-as-industry-leader-on-fortune-worlds-most-admired-companies-2026-List/)) Recent developments suggest continued momentum in both growth and capital management. In February 2026, MetLife reported full-year 2025 results showing growth in premiums, fees and other revenues, as well as higher adjusted earnings, while returning substantial capital to shareholders. In 2025, it announced a $10 billion variable annuity risk transfer transaction, underscoring its ability to structure large-scale balance-sheet optimization deals. MetLife also broadened its product set with new employee-focused offerings, including a cancer support benefit and digital protection initiatives tied to mental health and fraud prevention. Overall, the company remains positioned as a diversified, globally relevant insurer with a strong U.S. listed presence on the NYSE. ([metlife.com](https://www.metlife.com/about-us/newsroom/2026/february/metlife-announces-full-year-and-4q-2025-results/?utm_source=openai))
